SOP Guide for Pharma

Ointments: SOP for Handling Deviation Reports – V 2.0

SOP for Handling Deviation Reports – V 2.0

Procedure for Handling Deviation Reports

Department Quality Assurance (QA)/Quality Control (QC)/Production
SOP No. SOP/Ointment/086
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a standardized approach for handling, investigating, and documenting deviations in pharmaceutical manufacturing processes. Proper deviation management ensures compliance with Good Manufacturing Practices (GMP) and regulatory requirements while maintaining product quality.

2. Scope

This SOP applies to all personnel in the Quality Assurance (QA), Quality Control (QC), and Production departments responsible for identifying, reporting, investigating, and closing deviation reports in the manufacturing process.

3. Responsibilities

  • Production Operator: Identifies and reports deviations observed during production.
  • Production Supervisor: Investigates deviations and ensures corrective actions are taken.
  • Quality Control (QC) Analyst: Evaluates deviations affecting product quality and performs necessary testing.
  • Quality Assurance (QA) Officer: Reviews deviation reports, initiates corrective actions, and ensures compliance with regulatory standards.
  • QA Manager: Approves the final deviation report and ensures preventive measures are implemented.

4. Accountability

The QA and Production Managers are accountable for ensuring that all deviations are properly recorded, investigated, and resolved in compliance with GMP and regulatory requirements.

5. Procedure

5.1 Identification of Deviations

  • Deviations may occur in manufacturing, packaging, labeling, testing, or documentation.
  • Common types of deviations
include:
  • Minor: Deviations with minimal impact on product quality.
  • Major: Deviations that may impact product quality or regulatory compliance.
  • Critical: Deviations that affect patient safety or lead to batch rejection.
  • Any observed deviation must be reported immediately to the Production Supervisor and QA department.
  • 5.2 Deviation Reporting

    • Complete a Deviation Report Form with the following details:
      • Date and time of occurrence
      • Location and process step where the deviation occurred
      • Detailed description of the deviation
      • Immediate corrective action taken (if any)
    • Submit the Deviation Report to the QA department for review.

    5.3 Deviation Investigation

    • QA assigns an investigator to assess the deviation.
    • The investigation should determine:
      • Root cause of the deviation
      • Impact on product quality and safety
      • Potential recurrence of the issue
    • Conduct a risk assessment if the deviation affects product safety.

    5.4 Corrective and Preventive Actions (CAPA)

    • Based on the investigation findings, develop a Corrective and Preventive Action (CAPA) plan.
    • Corrective actions should address the root cause of the deviation.
    • Preventive measures should be implemented to prevent recurrence.
    • Examples of CAPA include:
      • Updating SOPs or training personnel
      • Modifying equipment settings or processes
      • Improving material handling procedures

    5.5 Approval and Closure

    • QA Manager reviews and approves the deviation report.
    • Ensure all corrective actions are implemented before closing the deviation.
    • Record the deviation closure date and store the report for audit purposes.

    5.6 Documentation

    • Maintain all deviation reports in the Deviation Log.
    • Ensure traceability of deviations, investigations, and CAPA actions.
    • QA must review deviation trends periodically for continuous improvement.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • CAPA – Corrective and Preventive Action

    7. Documents

    • Deviation Report Form (Annexure-1)
    • Deviation Log (Annexure-2)

    8. References

    • WHO GMP Guidelines for Pharmaceutical Manufacturing
    • ICH Q9 – Quality Risk Management
    • ICH Q10 – Pharmaceutical Quality System

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Deviation Report Form

    Date Batch Number Process Step Deviation Type Root Cause Corrective Action Approved By
    01/02/2025 OINT-101 Mixing Major Temperature fluctuation Machine recalibrated QA Officer
    02/02/2025 OINT-102 Filling Minor Volume variation Operator re-trained QA Officer

    Annexure-2: Deviation Log

    Date Batch Number Deviation Description CAPA Implemented Final Status Verified By
    01/02/2025 OINT-101 Mixing temperature deviation Recalibration Closed QA Head
    02/02/2025 OINT-102 Volume discrepancy Operator retraining Closed QA Head

    12. Revision History:

    Exit mobile version